FDA Updates Reynolds MRTP

    Courtesy: US FDA

    The U.S. Food and Drug Administration has added the redacted “September 14, 2020 Amendment: Timing to Respond to September 1, 2020, FDA Deficiency Letter” to R.J. Reynolds Tobacco Company’s modified-risk tobacco product (MRTP) applications.

    On Dec. 18, 2017, the FDA filed for substantive scientific review of six MRTP applications from R.J. Reynolds Tobacco Company for the following smokeless tobacco products: Camel Snus Frost, Camel Snus Frost Large, Camel Snus Mellow, Camel Snus Mint, Camel Snus Robust and Camel Snus Winterchill.

    On Oct. 25, 2022, R.J. Reynolds Tobacco Company requested to withdraw these applications from FDA review.